- 英文名称
- Periplocin
- 分子式
- C36H56O13
- 分子量
- 696.82
- 中文别名
- 杠柳苷; 五加皮苷G; 萝蘑毒苷; 4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-二羟基-3-(((2R,4S,5R,6R)-4-甲氧基-6-甲基-5-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-10,13-二甲基十六氢-1H-环戊烷[a]菲-17-基)呋喃-2(5H)-酮; 3-[(3S,5S,10R,13R,14S,17R)-3-[(2R,5R)-6-[[(3R,6S)-4,6-二羟基-2-甲基氧杂环己-3-基]氧甲基]-3,5-二羟基-4-甲氧基氧杂环己-2-基]氧基-5,14-二羟基-10,13-二甲基-2,3,4,6,7,8,9,11,12,15,16,17-十二氢-1H-环戊并[a]菲-17-基]-2H-呋喃-5-酮; Periplocoside; Glucoperiplocymarin; 3β-[(4-O-β-D-Glucopyranosyl-3-O-methyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-5β,14β-card-20(22)-enolide; Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-, (3β,5β)-; 4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-Dihydroxy-3-(((2R,4S,5R,6R)-4-methoxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; Periplogenin + D-cymarose + D-glucose; corchorusoside C; (3β,5β)-3-{[2,6-Dideoxy-4-O-(β-D-glucopyranosyl)-β-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxycard-20(22)-enolide; (3β,5β)-3-{[2,6-Dideoxy-4-O-(β-D-glucopyranosyl)-β-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxycard-20(22)-enolido(2-)
- 用途
- 作为香加皮的主要有效成分，用于治疗慢性充血性心力衰竭和心脏性浮肿；具有抑制肝癌、肺癌、食管癌、膀胱癌、宫颈癌、乳腺癌等多种癌细胞生长的活性，可用于生命科学研究及相关药理实验。
